S.-PETERBURGSKIJ NAUCHNO-ISSLEDOVATEL'SKIJ INSTITU;SKOROJ POMOSHCHI IM I I DZHANE
发明人:
IL'INA V.A.,SHAKH B.N.,BORODAJ E.A.,VASHETKO R.V.
申请号：
RU19980113103
公开号：
RU2139537(C1)
申请日:
1998.06.30
申请国别(地区):
俄罗斯
年份:
1999
代理人:
摘要：
FIELD: medicine. SUBSTANCE: method involves determining alpha 1-antitripsine inhibitor (callicreine) activity in arterial and mixed venous blood serum, medium molecular mass contents and spontaneous luminescence in the whole blood. Respiratory distress syndrome risk coefficient is calculated for each item. EFFECT: enhanced effectiveness of early stage diagnosis.
